Recurrent pneumococcal meningitis in a splenectomised HIV-infected patient

<p>Abstract</p> <p>Background</p> <p><it>Streptococcus pneumoniae </it>is a major cause of human disease, especially in pre-school children and elderly people, as well as in special risk groups such as asplenic, antibody deficient patients, or presenting dis...

Full description

Saved in:
Bibliographic Details
Main Authors: Quesne Gilles (Author), Abachin Eric (Author), Poyart Claire (Author), Veuillez Veronique (Author), Morand Philippe C (Author), Dupont Bertrand (Author), Berche Patrick (Author), Viard Jean-Paul (Author)
Format: Book
Published: BMC, 2003-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_06df72b162dc4a4f972d128a6b34c8a5
042 |a dc 
100 1 0 |a Quesne Gilles  |e author 
700 1 0 |a Abachin Eric  |e author 
700 1 0 |a Poyart Claire  |e author 
700 1 0 |a Veuillez Veronique  |e author 
700 1 0 |a Morand Philippe C  |e author 
700 1 0 |a Dupont Bertrand  |e author 
700 1 0 |a Berche Patrick  |e author 
700 1 0 |a Viard Jean-Paul  |e author 
245 0 0 |a Recurrent pneumococcal meningitis in a splenectomised HIV-infected patient 
260 |b BMC,   |c 2003-11-01T00:00:00Z. 
500 |a 10.1186/1476-0711-2-9 
500 |a 1476-0711 
520 |a <p>Abstract</p> <p>Background</p> <p><it>Streptococcus pneumoniae </it>is a major cause of human disease, especially in pre-school children and elderly people, as well as in special risk groups such as asplenic, antibody deficient patients, or presenting disruption of natural barriers. The occurrence of pneumococcal disease has increased with the onset of the HIV epidemic and the emergence of drug-resistance.</p> <p>Case presentation</p> <p>We report the case of an HIV-1-infected patient who experienced three episodes of recurrent pneumococcal meningitis over a 4-year period, despite chemoprophylaxis and capsular vaccination.</p> <p>Conclusions</p> <p>Efficacy of anti-pneumococcal chemoprophylaxis and vaccination in HIV-infected patients are discussed in the light of this particular case.</p> 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Infectious and parasitic diseases 
690 |a RC109-216 
690 |a Microbiology 
690 |a QR1-502 
655 7 |a article  |2 local 
786 0 |n Annals of Clinical Microbiology and Antimicrobials, Vol 2, Iss 1, p 9 (2003) 
787 0 |n http://www.ann-clinmicrob.com/content/2/1/9 
787 0 |n https://doaj.org/toc/1476-0711 
856 4 1 |u https://doaj.org/article/06df72b162dc4a4f972d128a6b34c8a5  |z Connect to this object online.